AVTX
Price
$12.42
Change
+$0.69 (+5.88%)
Updated
May 9, 8:57 AM EST
MRSN
Price
$2.96
Change
-$0.44 (-12.94%)
Updated
May 9, 9:22 AM EST
Earnings call today
Ad is loading...

AVTX vs MRSN

Header iconAVTX vs MRSN Comparison
Open Charts AVTX vs MRSNBanner chart's image
Avalo Therapeutics
Price$12.42
Change+$0.69 (+5.88%)
Volume$100
CapitalizationN/A
Mersana Therapeutics
Price$2.96
Change-$0.44 (-12.94%)
Volume$3.3K
CapitalizationN/A
View a ticker or compare two or three
AVTX vs MRSN Comparison Chart

Loading...

AVTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRSNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AVTX vs. MRSN commentary
May 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and MRSN is a Hold.

COMPARISON
Comparison
May 09, 2024
Stock price -- (AVTX: $11.73 vs. MRSN: $3.40)
Brand notoriety: AVTX and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 16% vs. MRSN: 44%
Market capitalization -- AVTX: $12.13M vs. MRSN: $416.03M
AVTX [@Biotechnology] is valued at $12.13M. MRSN’s [@Biotechnology] market capitalization is $416.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 4 TA indicator(s) are bullish while MRSN’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 4 bullish, 3 bearish.
  • MRSN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than MRSN.

Price Growth

AVTX (@Biotechnology) experienced а -26.69% price change this week, while MRSN (@Biotechnology) price change was +0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was -4.54%, and the average quarterly price growth was +71.32%.

Reported Earning Dates

AVTX is expected to report earnings on Apr 01, 2024.

MRSN is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AVTX with price predictions.
OPEN
A.I.dvisor published
a Summary for MRSN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRSN($416M) has a higher market cap than AVTX($12.1M). MRSN YTD gains are higher at: 46.552 vs. AVTX (28.901).
AVTXMRSNAVTX / MRSN
Capitalization12.1M416M3%
EBITDAN/AN/A-
Gain YTD28.90146.55262%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AVTX vs MRSN: Fundamental Ratings
AVTX
MRSN
OUTLOOK RATING
1..100
785
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4041
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
2750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRSN's Valuation (69) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that MRSN’s stock grew similarly to AVTX’s over the last 12 months.

MRSN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that MRSN’s stock grew similarly to AVTX’s over the last 12 months.

MRSN's SMR Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that MRSN’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as MRSN (41) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXMRSN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AVTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRSNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POGRX38.42-0.03
-0.08%
PRIMECAP Odyssey Growth
KGIIX13.91-0.02
-0.14%
Kopernik International I
AFGZX30.94-0.06
-0.19%
Alger Global Focus Z
BIIGX32.70-0.32
-0.97%
Buffalo Growth Institutional
DLDCX44.08-0.46
-1.03%
BNY Mellon Natural Resources C

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-11.47%
FGEN - AVTX
56%
Loosely correlated
-17.52%
MRSN - AVTX
37%
Loosely correlated
-3.55%
PGEN - AVTX
34%
Loosely correlated
-3.62%
BGNE - AVTX
32%
Poorly correlated
+2.42%
DYN - AVTX
32%
Poorly correlated
+0.16%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with MDGL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-3.55%
MDGL - MRSN
45%
Loosely correlated
-4.55%
ZNTL - MRSN
40%
Loosely correlated
+0.97%
AVTX - MRSN
38%
Loosely correlated
-11.47%
BHVN - MRSN
38%
Loosely correlated
-1.66%
ARRY - MRSN
36%
Loosely correlated
-6.57%
More